PDRN / Polynucleotide Injections
PDRN and polynucleotide-based treatments use DNA-derived compounds in injectable skin-quality protocols. They may be used in selected areas such as the face, neck and décolletage, depending on the specific product and treatment plan. The approach is defined by its focus on supporting skin quality, with the area and the product chosen together in planning.
How it is performed
A DNA-derived compound is delivered into the selected area as part of an injectable skin-quality protocol. The specific product and the placement are chosen to suit the region and the plan agreed with the patient.
Where it is used
- Face
- Neck
- Décolletage
- As agreed in the treatment plan
The practitioner reviews the area, selects the appropriate product and explains how the treatment sits within the wider skin-quality program.